These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 32025372)

  • 21. High preoperative serum CA19-9 level is predictive of poor prognosis for patients with colorectal liver oligometastases undergoing hepatic resection.
    Lu Z; Peng J; Wang Z; Pan Z; Yuan Y; Wan D; Li B
    Med Oncol; 2016 Nov; 33(11):121. PubMed ID: 27722895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neoadjuvant Chemotherapy Followed by Radiofrequency Ablation May Be a New Treatment Modality for Colorectal Liver Metastasis: A Propensity Score Matching Comparative Study.
    Chen Y; Huang Y; Xu L; Wu J; Han F; Jiang H; Zheng P; Xu D; Zhang Y
    Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neoadjuvant chemotherapy improves overall survival in resectable colorectal liver metastases patients with high clinical risk scores-- A retrospective, propensity score matching analysis.
    Chen FL; Wang YY; Liu W; Xing BC
    Front Oncol; 2022; 12():973418. PubMed ID: 36132151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative study of ultrasound-guided percutaneous microwave ablation and surgical resection for colorectal cancer with liver metastasis].
    Huang Z; Li KY; Zhou PP; Wu XB; Li SS
    Zhonghua Yi Xue Za Zhi; 2020 Mar; 100(9):696-701. PubMed ID: 32187914
    [No Abstract]   [Full Text] [Related]  

  • 25. Early recurrence in patients undergoing curative resection of colorectal liver oligometastases: identification of its clinical characteristics, risk factors, and prognosis.
    Lin J; Peng J; Zhao Y; Luo B; Zhao Y; Deng Y; Sui Q; Gao Y; Zeng Z; Lu Z; Pan Z
    J Cancer Res Clin Oncol; 2018 Feb; 144(2):359-369. PubMed ID: 29128882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microwave ablation versus resection for colorectal cancer liver metastases - A propensity score analysis from a population-based nationwide registry.
    Tinguely P; Dal G; Bottai M; Nilsson H; Freedman J; Engstrand J
    Eur J Surg Oncol; 2020 Mar; 46(3):476-485. PubMed ID: 31837931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ten-Year Outcomes of Percutaneous Radiofrequency Ablation for Colorectal Cancer Liver Metastases in Perivascular vs. Non-Perivascular Locations: A Propensity-Score Matched Study.
    Jiang B; Luo H; Yan K; Zhang Z; Li X; Wu W; Yang W; Chen M
    Front Oncol; 2020; 10():553556. PubMed ID: 33178581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of colorectal resection combined with intraoperative radiofrequency ablation in treating colorectal cancer with liver metastasis and analysis of its prognosis.
    Fu T; He L; Liu F
    J BUON; 2020; 25(5):2171-2179. PubMed ID: 33277832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recurrence Beyond the Milan Criteria of HBV-Related Single Hepatocellular Carcinoma of 2-3 cm: Comparison of Resection and Ablation.
    Chen S; Ma W; Shen L; Wu Y; Qi H; Cao F; Huang T; Fan W
    Front Oncol; 2021; 11():757149. PubMed ID: 34733791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colorectal liver metastases: recurrence and survival following hepatic resection, radiofrequency ablation, and combined resection-radiofrequency ablation.
    Gleisner AL; Choti MA; Assumpcao L; Nathan H; Schulick RD; Pawlik TM
    Arch Surg; 2008 Dec; 143(12):1204-12. PubMed ID: 19075173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiosurgery in the management of brain metastasis: a retrospective single-center study comparing Gamma Knife and LINAC treatment.
    Tuleasca C; Negretti L; Faouzi M; Magaddino V; Gevaert T; von Elm E; Levivier M
    J Neurosurg; 2018 Feb; 128(2):352-361. PubMed ID: 28338441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of neo-adjuvant chemotherapy in patients with resectable colorectal liver metastases: Clinical risk score as possible discriminator.
    Ayez N; van der Stok EP; Grünhagen DJ; Rothbarth J; van Meerten E; Eggermont AM; Verhoef C
    Eur J Surg Oncol; 2015 Jul; 41(7):859-67. PubMed ID: 25979624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term outcomes of ultrasound-guided percutaneous microwave ablation versus resection for colorectal cancer liver metastases: a propensity-score matched study.
    Huang Z; Pan Y; Zhou P; Li S; Li K
    Int J Hyperthermia; 2021; 38(1):1276-1284. PubMed ID: 34423716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of thermal ablation in the management of colorectal liver metastasis.
    Takahashi H; Berber E
    Hepatobiliary Surg Nutr; 2020 Feb; 9(1):49-58. PubMed ID: 32140478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiofrequency ablation versus traditional liver resection and chemotherapy for liver metastases from gastric cancer.
    Tang K; Zhang B; Dong L; Wang L; Tang Z
    J Int Med Res; 2020 Jul; 48(7):300060520940509. PubMed ID: 32687001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up.
    Solbiati L; Ahmed M; Cova L; Ierace T; Brioschi M; Goldberg SN
    Radiology; 2012 Dec; 265(3):958-68. PubMed ID: 23091175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microwave ablation with or without resection for colorectal liver metastases.
    Stättner S; Jones RP; Yip VS; Buchanan K; Poston GJ; Malik HZ; Fenwick SW
    Eur J Surg Oncol; 2013 Aug; 39(8):844-9. PubMed ID: 23769976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of treatment modality and number of lesions on recurrence and survival outcomes after treatment of colorectal cancer liver metastases.
    Saxena A; Chua TC; Chu FC; Ng KM; Herle P; Morris DL
    J Gastrointest Oncol; 2014 Feb; 5(1):46-56. PubMed ID: 24490042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome after laparoscopic radiofrequency ablation of technically resectable colorectal liver metastases.
    Hammill CW; Billingsley KG; Cassera MA; Wolf RF; Ujiki MB; Hansen PD
    Ann Surg Oncol; 2011 Jul; 18(7):1947-54. PubMed ID: 21399885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Percutaneous CT-guided Radiofrequency Ablation for Lymph Node Oligometastases from Hepatocellular Carcinoma: A Propensity Score-matching Analysis.
    Pan T; Xie QK; Lv N; Li XS; Mu LW; Wu PH; Zhao M
    Radiology; 2017 Jan; 282(1):259-270. PubMed ID: 27399327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.